Cargando…

Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus

PURPOSE: To investigate risk factors for the development and progression of diabetic retinopathy (DR) and long‐term visual outcomes in Dutch patients with type 1 diabetes mellitus (T1DM). METHODS: Cumulative incidences were calculated for DR, vision‐threatening DR (VTDR), defined as (pre)proliferati...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreur, Vivian, van Asten, Freekje, Ng, Heijan, Weeda, Jack, Groenewoud, Joannes M.M., Tack, Cees J., Hoyng, Carel B., de Jong, Eiko K., Klaver, Caroline C.W., Jeroen Klevering, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174939/
https://www.ncbi.nlm.nih.gov/pubmed/30188024
http://dx.doi.org/10.1111/aos.13815
_version_ 1783361391987523584
author Schreur, Vivian
van Asten, Freekje
Ng, Heijan
Weeda, Jack
Groenewoud, Joannes M.M.
Tack, Cees J.
Hoyng, Carel B.
de Jong, Eiko K.
Klaver, Caroline C.W.
Jeroen Klevering, B.
author_facet Schreur, Vivian
van Asten, Freekje
Ng, Heijan
Weeda, Jack
Groenewoud, Joannes M.M.
Tack, Cees J.
Hoyng, Carel B.
de Jong, Eiko K.
Klaver, Caroline C.W.
Jeroen Klevering, B.
author_sort Schreur, Vivian
collection PubMed
description PURPOSE: To investigate risk factors for the development and progression of diabetic retinopathy (DR) and long‐term visual outcomes in Dutch patients with type 1 diabetes mellitus (T1DM). METHODS: Cumulative incidences were calculated for DR, vision‐threatening DR (VTDR), defined as (pre)proliferative DR and diabetic macular oedema, and best‐corrected visual acuity (BCVA) <0.5 and <0.3 at the most recent eye examination. The following factors were assessed: duration of diabetes, age of onset of T1DM, gender, mean HbA1c, HbA1c variability (defined as coefficient of variation of five separate HbA1c measurements), mean arterial blood pressure, body mass index, albuminuria and lipid profile. We used multivariable Cox regression models to identify factors associated with DR development and progression to VTDR. RESULTS: We found 25‐year cumulative incidences of 63% for DR, 21% for VTDR, 2% for BCVA <0.5, and 1% for BCVA <0.3. Mean HbA1c (HR 1.023, p < 0.001), HbA1c variability (HR 1.054, p < 0.001), age of onset of T1DM (HR 1.024, p < 0.001), HDL cholesterol (HR 0.502, p = 0.002) and total cholesterol (HR 1.210, p = 0.029) showed an independent association with faster development of any form of DR. The mean HbA1c (HR 1.023, p < 0.001) and the presence of albuminuria (HR 2.940, p = 0.028) were associated with faster progression to VTDR. CONCLUSION: These data show relatively low cumulative incidences of DR, VTDR and visual impairment. Higher mean HbA1c, HbA1c variability, age of onset of T1DM and total cholesterol were independently associated with the risk of DR development, and a protective association was found for HDL cholesterol in subjects with T1DM. Mean HbA1c and presence of albuminuria were associated with progression of DR.
format Online
Article
Text
id pubmed-6174939
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61749392018-10-15 Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus Schreur, Vivian van Asten, Freekje Ng, Heijan Weeda, Jack Groenewoud, Joannes M.M. Tack, Cees J. Hoyng, Carel B. de Jong, Eiko K. Klaver, Caroline C.W. Jeroen Klevering, B. Acta Ophthalmol Original Articles PURPOSE: To investigate risk factors for the development and progression of diabetic retinopathy (DR) and long‐term visual outcomes in Dutch patients with type 1 diabetes mellitus (T1DM). METHODS: Cumulative incidences were calculated for DR, vision‐threatening DR (VTDR), defined as (pre)proliferative DR and diabetic macular oedema, and best‐corrected visual acuity (BCVA) <0.5 and <0.3 at the most recent eye examination. The following factors were assessed: duration of diabetes, age of onset of T1DM, gender, mean HbA1c, HbA1c variability (defined as coefficient of variation of five separate HbA1c measurements), mean arterial blood pressure, body mass index, albuminuria and lipid profile. We used multivariable Cox regression models to identify factors associated with DR development and progression to VTDR. RESULTS: We found 25‐year cumulative incidences of 63% for DR, 21% for VTDR, 2% for BCVA <0.5, and 1% for BCVA <0.3. Mean HbA1c (HR 1.023, p < 0.001), HbA1c variability (HR 1.054, p < 0.001), age of onset of T1DM (HR 1.024, p < 0.001), HDL cholesterol (HR 0.502, p = 0.002) and total cholesterol (HR 1.210, p = 0.029) showed an independent association with faster development of any form of DR. The mean HbA1c (HR 1.023, p < 0.001) and the presence of albuminuria (HR 2.940, p = 0.028) were associated with faster progression to VTDR. CONCLUSION: These data show relatively low cumulative incidences of DR, VTDR and visual impairment. Higher mean HbA1c, HbA1c variability, age of onset of T1DM and total cholesterol were independently associated with the risk of DR development, and a protective association was found for HDL cholesterol in subjects with T1DM. Mean HbA1c and presence of albuminuria were associated with progression of DR. John Wiley and Sons Inc. 2018-09-06 2018-08 /pmc/articles/PMC6174939/ /pubmed/30188024 http://dx.doi.org/10.1111/aos.13815 Text en © 2018 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Schreur, Vivian
van Asten, Freekje
Ng, Heijan
Weeda, Jack
Groenewoud, Joannes M.M.
Tack, Cees J.
Hoyng, Carel B.
de Jong, Eiko K.
Klaver, Caroline C.W.
Jeroen Klevering, B.
Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus
title Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus
title_full Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus
title_fullStr Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus
title_full_unstemmed Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus
title_short Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus
title_sort risk factors for development and progression of diabetic retinopathy in dutch patients with type 1 diabetes mellitus
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174939/
https://www.ncbi.nlm.nih.gov/pubmed/30188024
http://dx.doi.org/10.1111/aos.13815
work_keys_str_mv AT schreurvivian riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus
AT vanastenfreekje riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus
AT ngheijan riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus
AT weedajack riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus
AT groenewoudjoannesmm riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus
AT tackceesj riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus
AT hoyngcarelb riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus
AT dejongeikok riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus
AT klavercarolinecw riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus
AT jeroenkleveringb riskfactorsfordevelopmentandprogressionofdiabeticretinopathyindutchpatientswithtype1diabetesmellitus